Treatments for angiosarcoma can be intense, and it is important to monitor how your body responds. Common side effects include: Surgical Recovery: Pain, swelling and a limited range of motion in the ...

The Alliance AO91902 trial investigated whether adding immunotherapy to chemotherapy would improve outcomes for patients with advanced angiosarcoma. Although immunotherapy has become a mainstay of ...

Paclitaxel remains first-line for cutaneous angiosarcoma, but absence of validated second-line therapy creates a major unmet ...

Seven years after completing breast cancer treatment, Angelia Carpenter was shocked to discover she had angiosarcoma, a rare cancer that may have been associated with her breast cancer treatment. When ...

Angiosarcoma is an aggressive malignancy derived from endothelial cells, characterised by its rapid progression, heterogeneity and distinct clinical challenges. As a subset of soft tissue sarcomas, ...

PAX3/7-FOXO1 fusions by fluorescent in situ hybridization (FISH) using an adult rhabdomyosarcoma tissue microarray. Background: Surgical management of cutaneous angiosarcoma (AS) of the head and neck ...

Two rare presentations and treatments of Ewing's sarcoma: A need for a standard treatment approach. Pilot study of redirected autologous T cells engineered to contain anti-CD19 attached to TCRζ and ...

“[...] PHA is a rare yet aggressive mesenchymal tumor of the liver, which requires a multi-disciplinary approach to achieve the best patient outcomes.” “In our ...

Although relatively rare, soft tissue sarcoma after breast cancer treatment was linked most strongly to treatment with radiation, according to data from two large U.S. cohorts of breast cancer ...

Angiosarcoma of the gastrointestinal tract is an exceedingly rare and aggressive vascular tumour that arises from the endothelial cells lining blood vessels. Although primary angiosarcoma in this ...